Phenotyping of Tumor Infiltrating Immune Cells Using Mass-cytometry (CyTOF)
Overview
Authors
Affiliations
The anti-tumor immune response plays a crucial role in cancer patient outcome as well as in response to the growing family of immunotherapeutic treatments. Improving patient prognostic and therapeutic management requires a better knowledge of the tumor microenvironment, for which a deep characterization of tumor-infiltrating immune populations is instrumental. Mass cytometry represents an excellent tool in tumor Immunology, as it allows the simultaneous analysis of >40 markers on single cells. In this chapter, we review challenging technical aspects of the mass cytometry phenotyping of tumor infiltrating immune cells, focusing on fresh human solid tumor samples. We first explain how to design mass cytometry experiments, then provide detailed protocols to isolate mononuclear immune cells from solid tissues and to stain them for an acquisition on a mass cytometer. We also discuss how to optimize the preparation of single immune cell samples, and how to ensure the reproducibility of data generated from distinct fresh human samples. Finally, we provide troubleshooting suggestions for difficult sample acquisitions on a mass cytometer.
Machine learning integrative approaches to advance computational immunology.
Curion F, Theis F Genome Med. 2024; 16(1):80.
PMID: 38862979 PMC: 11165829. DOI: 10.1186/s13073-024-01350-3.
Lopez Janeiro A, Wong E, Jimenez-Sanchez D, Ortiz de Solorzano C, Lozano M, Teijeira A J Immunother Cancer. 2024; 12(5).
PMID: 38821717 PMC: 11149121. DOI: 10.1136/jitc-2023-008589.
Zhu D, Lu Y, Yang S, Hu T, Tan C, Liang R Adv Sci (Weinh). 2024; 11(26):e2401064.
PMID: 38708711 PMC: 11234469. DOI: 10.1002/advs.202401064.
Emerging measurements for tumor-infiltrating lymphocytes in breast cancer.
Wu R, Horimoto Y, Oshi M, Benesch M, Khoury T, Takabe K Jpn J Clin Oncol. 2024; 54(6):620-629.
PMID: 38521965 PMC: 11144297. DOI: 10.1093/jjco/hyae033.
Full spectrum flow cytometry and mass cytometry: A 32-marker panel comparison.
Jaimes M, Leipold M, Kraker G, Amir E, Maecker H, Lannigan J Cytometry A. 2022; 101(11):942-959.
PMID: 35593221 PMC: 9790709. DOI: 10.1002/cyto.a.24565.